Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2023-03-16 00:00:00 ET · period of report 2023-03-15 · accession 0001628280-23-008322 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-16 | 2023-03-15 | MYGN | Lambert Nicole | COO | A - Grant | $0.00 | +39.4K | 254.6K | +18% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-15 | A | A | 39,405 | $0.00 | 254,625 | D | — | — |